TENORA, Lukáš, Juraj GALETA, Eva ŘEZNÍČKOVÁ, Vladimír KRYŠTOF and Milan POTÁČEK. Application of Pd-Catalyzed Cross-Coupling Reactions in the Synthesis of 5,5-Dimethyl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazoles that inhibit ALK5 Kinase. The Journal of Organic Chemistry. American Chemical Society, vol. 81, No 23, p. 11841-11856. ISSN 0022-3263. doi:10.1021/acs.joc.6b02230. 2016.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Application of Pd-Catalyzed Cross-Coupling Reactions in the Synthesis of 5,5-Dimethyl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazoles that inhibit ALK5 Kinase
Authors TENORA, Lukáš (203 Czech Republic, belonging to the institution), Juraj GALETA (703 Slovakia, belonging to the institution), Eva ŘEZNÍČKOVÁ (203 Czech Republic), Vladimír KRYŠTOF (203 Czech Republic) and Milan POTÁČEK (203 Czech Republic, guarantor, belonging to the institution).
Edition The Journal of Organic Chemistry, American Chemical Society, 2016, 0022-3263.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10401 Organic chemistry
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.849
RIV identification code RIV/00216224:14310/16:00091403
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1021/acs.joc.6b02230
UT WoS 000389396400032
Keywords in English Cross-Coupling reactions; Pd catalysed; 4H-pyrrolo[1;2-b]pyrazoles; ALK5 Kinase inhibitors;
Tags AKR, rivok
Tags International impact, Reviewed
Changed by Changed by: Ing. Andrea Mikešková, učo 137293. Changed: 30/3/2017 10:15.
Abstract
C-H activation of position 3 of a substituted pyrazole ring catalyzed by palladium(II) was straightforward and convenient for arylated or heteroarylated 5,5-dimethyl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazoles. Moreover, we introduced simple protection of the nitrogen in the pyridin-2-yl directing group, which otherwise does not allow cross-coupling reaction, by transformation to the N-oxide. Selected final products were reasonably selective ALK5 kinase inhibitors.
PrintDisplayed: 18/4/2024 11:53